175 related articles for article (PubMed ID: 36653236)
1. Molecular testing in melanoma for the surgical pathologist.
Andea AA
Pathology; 2023 Mar; 55(2):245-257. PubMed ID: 36653236
[TBL] [Abstract][Full Text] [Related]
2. Molecular testing for melanocytic tumors: a practical update.
Andea AA
Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
[TBL] [Abstract][Full Text] [Related]
3. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
4. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
5. Melanocytic lesions with blue naevus-like (dendritic) morphology: an update with an emphasis on histopathological, immunophenotypic, and molecular features.
Cho WC; Prieto VG; Aung PP
Histopathology; 2021 Sep; 79(3):291-305. PubMed ID: 33772838
[TBL] [Abstract][Full Text] [Related]
6. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
Kerr KF; Elder DE; Piepkorn MW; Knezevich SR; Eguchi MM; Shucard HL; Reisch LM; Elmore JG; Barnhill RL
JAMA Dermatol; 2023 Dec; 159(12):1315-1322. PubMed ID: 37938821
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal tumours with melanocytic expression: a potential pitfall in the differential diagnosis of malignant melanoma.
Saleh JS; Whittington CP; Bresler SC; Patel RM
Pathology; 2023 Mar; 55(2):258-268. PubMed ID: 36639332
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
9. Molecular techniques for predicting behaviour in melanocytic neoplasms.
Lee CY; Gerami P
Pathology; 2016 Feb; 48(2):142-6. PubMed ID: 27020386
[TBL] [Abstract][Full Text] [Related]
10. Differential diagnosis of heavily pigmented melanocytic lesions: challenges and diagnostic approach.
Aung PP; Mutyambizi KK; Danialan R; Ivan D; Prieto VG
J Clin Pathol; 2015 Dec; 68(12):963-70. PubMed ID: 26602414
[TBL] [Abstract][Full Text] [Related]
11. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
Xavier-Junior JCC; Ocanha-Xavier JP
Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnostics for ambiguous melanocytic tumors.
Shahbain H; Cooper C; Gerami P
Semin Cutan Med Surg; 2012 Dec; 31(4):274-8. PubMed ID: 23174498
[TBL] [Abstract][Full Text] [Related]
13. [Molecular diagnostic contribution in melanocytic lesions analysis (FISH/CGH)].
de la Fouchardière A; Vergier B
Ann Pathol; 2011 Nov; 31(5 Suppl):S115-6. PubMed ID: 22054446
[No Abstract] [Full Text] [Related]
14. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms.
Lang UE; Torres R; Cheung C; Vladar EK; McCalmont TH; Kim J; Judson-Torres RL
J Invest Dermatol; 2020 Jul; 140(7):1401-1409.e2. PubMed ID: 31978411
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
16. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous melanocytic tumors. Case 2].
Castillo C
Ann Pathol; 2016 Oct; 36(5):322-325. PubMed ID: 27639774
[No Abstract] [Full Text] [Related]
18. Diagnostic utility of the 23-gene expression profile test for an atypical intradermal melanocytic proliferation.
Marks E; Badia AA; Goldberg MS
Per Med; 2024 Jan; 21(1):21-27. PubMed ID: 38059357
[TBL] [Abstract][Full Text] [Related]
19. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
[TBL] [Abstract][Full Text] [Related]
20. TERT and TERT promoter in melanocytic neoplasms: Current concepts in pathogenesis, diagnosis, and prognosis.
Motaparthi K; Kim J; Andea AA; Missall TA; Novoa RA; Vidal CI; Fung MA; Emanuel PO
J Cutan Pathol; 2020 Aug; 47(8):710-719. PubMed ID: 32202662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]